Clinical Trial Update: Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix [Phase 2]

View source ↗

Summary

This report notes the completion of a Phase 2 clinical trial evaluating interleukin-12 in patients with advanced or recurrent cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED